Abstract A17: The dual angiogenesis/heparanase inhibitor PG545 inhibits solid tumor progression in models of breast, prostate and liver cancer: A comparative assessment of once versus twice weekly administration schedules

Edward Hammond(American Cancer Society), Keith Dredge, Michelle Kappler(The University of Queensland), Thomas J. Gonda(University of South Australia), Ian Bytheway, Paul Handley, Maree T. Smith(The University of Queensland), Crystal McGirr
Molecular Cancer Therapeutics
December 1, 2009
10.1158/1535-7163.targ-09-a17
Cited by 3

Related Papers

A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
MYB function in normal and cancer cells
|Nature reviews. Cancer|2008|627
Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia
|Nature|1984|569
Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: The architecture of a transduced oncogene
|Cell|1982|539
Transcripts from the Cellular Homologs of Retroviral Oncogenes: Distribution Among Chicken Tissues
|Molecular and Cellular Biology|1982|402